vancomycin has been researched along with glucose, (beta-d)-isomer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, GM; Keis, S; Kobayashi, K; Rainey, FA; Rao, M; Smith, JM | 1 |
| Hossion, AM; Iwado, A; Kandahary, RK; Ogawa, W; Otsuka, N; Sasaki, K; Tsuchiya, T; Zamami, Y | 1 |
| Aubry, JM; Belmessieri, D; Duclos, MC; Duguet, N; Dumitrescu, O; Gozlan, C; Lemaire, M; Lina, G; Molinier, V; Redl, A | 1 |
3 other study(ies) available for vancomycin and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Enterococci with reduced susceptibility to vancomycin in New Zealand.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Diarrhea; DNA Fingerprinting; DNA, Bacterial; DNA, Ribosomal; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Feces; Glucosides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; New Zealand; Prevalence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2000 |
Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Drug Design; Enterococcus; Glucosides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quercetin; Vancomycin | 2010 |
Synthesis, surfactant properties and antimicrobial activities of methyl glycopyranoside ethers.
Topics: Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus faecalis; Enterococcus faecium; Glucosides; Gram-Positive Bacterial Infections; Humans; Listeria monocytogenes; Listeriosis; Methicillin; Methyl Ethers; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |